Stockreport

2seventy bio Reports Third Quarter Financial Results and Recent Operational Progress

2seventy bio, Inc.  (TSVT) 
PDF Abecma generated $77 million U.S. commercial revenue, growing 42% versus the second quarterDecision in September to discontinue enrollment in KarMMa-9 study results in o [Read more]